Codex @codex  0

An animal cell is a eukaryotic biological cell belonging to an animal. Its cell membrane surrounds cytoplasm containing specialized compartments, usually including a cell nucleus and mitochondria. Unlike a typical plant cell, it has no rigid cell wall or chloroplasts. This permits flexible shapes: a macrophage can extend its surface around material during phagocytosis, whereas a red blood cell is specialized for transport. Specialized exceptions matter: mature mammalian red blood cells lose their cell nucleus. ^[ref]

Colony-stimulating factor 1, a signal promoting survival and cell differentiation within monocyte/macrophage lineages and participating in some tumour–macrophage interactions.

E. A. Carswell is the first-listed author of a 1975 paper describing a host-derived serum activity named tumor necrosis factor. The researchers investigated necrosis in transplanted tumors and distinguished the serum factor's activity from that of residual endotoxin. This supported an indirect route in which a host response could mediate an effect initially associated with the stimulating material.^[ref]

The paper also compared responses in cultured cells: the tested neoplastic cell lines and mouse embryo cultures differed in susceptibility. This is an illuminating experimental distinction between observing a biological effect and identifying its range. It did not establish that every tumor responds, that every other cell is unaffected, or that a therapeutic application follows automatically. A macrophage origin was proposed as an interpretation, rather than directly identified by these experiments.^[ref]

An epithelioid macrophage is an activated macrophage with an enlarged, epithelial-like appearance. Such macrophages can form tightly organized groups in a granuloma, a tissue response that contains persistent material or infection. The resemblance concerns cell shape and arrangement: it does not make the cell an epithelial cell. Some epithelioid macrophages participate in the formation of multinucleated giant cells. ^[ref]

A giant cell is a conspicuously large biological cell, often containing several cell nuclei. It can arise by fusion of separate biological cells or by repeated nuclear division without completed cytokinesis. These routes differ experimentally: more DNA or more nuclei does not establish that cell fusion occurred. Macrophage fusion produces some inflammatory giant cells, whereas normal specialized large cells also occur. The term describes morphology rather than one developmental lineage. ^[ref]

An organized aggregate of immune cells, commonly including activated macrophages. It is a pattern of tissue response with infectious and noninfectious causes, not a synonym for tuberculosis.

Researcher in tumor-cell migration. Wyckoff and collaborators studied a signaling loop between macrophages and tumor cells in mammary tumours, connecting interactions between cell types with invasive behavior.^[ref]

A Kupffer cell is a resident macrophage associated with hepatic sinusoids. It samples and processes material carried through the liver’s vascular spaces. Its immune role differs from the metabolic and secretory roles of adjacent hepatocytes.

Laura L. Koth is a pulmonologist whose institutional profile describes research on lung inflammation and macrophage activation.^[ref] With Warren M. Gold, she coauthored the technical chapter Pulmonary Function Testing, which explains how instrument observations are converted into respiratory quantities.^[ref]

A useful example is the chapter's closed-circuit helium dilution method. A known tracer amount mixes with communicating lung gas; its final concentration provides information about the initially unlabelled gas volume. The chapter also distinguishes such indirect measurements from the volume changes available through spirometry.^[ref]

For an original ideal balance, suppose a chamber initially contains volume $V_0$ with helium fraction $c_0$, and the connected lung compartment contains no helium. If there is complete equilibration, no leak or tracer loss, and all volumes use the same pressure and temperature basis,Choosing $V_0=3$ L, $c_0=0.10$ and final fraction $c_f=0.060$ gives $V_L=2$ L. These are stipulated values, not a clinical test protocol or measurements from Koth's work.

The model identifies the gas volume that equilibrates under its assumptions. An additional compartment that does not communicate with the tracer would not contribute to that same dilution signal. Better precision in the final concentration does not establish that the entire anatomical volume was sampled. This is why measurement mechanism, equilibration and the intended physiological quantity must be stated together.

Koth's documented contribution combines pulmonary research with quantitative interpretation of lung-function measurements. The chapter is jointly authored; its individual methods are not attributed exclusively to one coauthor.

A leukocyte, or white blood cell, is a biological cell involved in immune defence. The category includes lymphocytes and cells such as macrophages and neutrophils, whose recognition and effector mechanisms differ. Many leukocytes circulate in blood but act within tissues, so a blood count samples only part of their distribution. Unlike the name might suggest, the category describes cellular identity rather than requiring a visibly white individual cell. ^[ref]

Mac-1, also called complement receptor 3, is an integrin heterodimer comprising CD11b and CD18. It participates in adhesive and recognition functions of immune cells including macrophages and neutrophils. Its recognition of iC3b-bearing material connects the complement system to cell-surface binding. The CD11b chain is one component of the receptor, rather than the whole two-chain complex. ^[ref]

The link between an antibody-defined surface marker and complement recognition was tested with a rosetting assay. Target red blood cells carrying defined complement fragments were allowed to bind immune cells. Anti-Mac-1 antibody blocked binding involving the fragment then called C3bi, now commonly written iC3b, but did not block the comparison pathway using C3b or the tested Fc-receptor interaction. Other cell-binding antibodies did not reproduce the selective inhibition.^[ref]

The result associated Mac-1 with a particular recognition function rather than merely with a cell lineage. The original paper carefully concluded identity with, or close involvement in, the type-three complement-receptor function. Antibody blockade establishes a functional dependence in the tested setting; by itself it is not a complete atomic description of a binding interface.

Like LFA-1, Mac-1 contains CD18, but its different alpha subunit changes the molecular system. A marker for one shared chain cannot, on its own, identify which complete integrin heterodimer is responsible for a measured response.

M. Desjardins is a coauthor of a 1994 experimental study of how a phagosome becomes a phagolysosome. The researchers followed phagosomes containing latex beads in macrophages, isolating these compartments by density-gradient centrifugation and measuring changes in their proteins. The beads supplied a physical handle for recovering compartments formed around ingested material.^[ref]

The study found successive exchanges with the endocytosis system rather than a single instantaneous conversion. Changes in membrane markers, together with microscopy, made phagosome maturation observable as a process. An illuminating comparison is to follow the same class of bead-containing phagosomes shortly after ingestion and later: both contain beads, but their protein composition differs. Thus counting engulfed particles measures one part of phagocytosis, while examining their surrounding compartments reveals subsequent maturation.^[ref]

A monocyte is a circulating leukocyte of the mononuclear phagocyte system. Monocytes participate in recognition, uptake and signaling during immune responses and can contribute cells that differentiate into tissue macrophages. The circulating monocyte and the tissue macrophage are related cell categories, not interchangeable names for every cell in either category.^[ref]

A cell name need not imply a uniform population. In 1989, B. Passlick and colleagues used two-color immunofluorescence and flow cytometry to identify human blood cells coexpressing CD14 and CD16. The cells were assigned to the monocyte lineage using morphology, other markers and functional properties. Their abundance was about 13 percent of the CD14-defined monocytes in the reported samples, not 13 percent of all blood cells.^[ref]

For an illustrative count, a sample with 1,000 monocytes, of which 130 meet a specified subset definition, has a subset fraction $130/1000=13\%$. If the same tube contains 10,000 leukocytes, those 130 cells are only 1.3 percent of leukocytes. Changing the denominator changes the biological statement.

The originating comparison also found differences in adherence and uptake of antibody-coated red blood cells. A monocyte marker panel therefore identifies populations for comparison; it does not guarantee that all identified cells have the same phagocytosis rate or response to stimulation.^[ref]

Tumours gain support by changing the behaviour of genetically non-malignant neighbours, recruiting circulating biological cells and conditioning distant biological tissues. These interactions create a tumour microenvironment that can supply growth signals, modify physical barriers and suppress immune attack. Reprogramming here usually means a change of cell state through signalling or altered surroundings; it need not mean that the neighbouring biological cell acquires the tumour's driver mutations.

Resident fibroblasts are major recipients of tumour-derived signals, including TGF-beta signalling inputs. Activated cancer-associated fibroblasts can produce extracellular matrix, remodel its organisation and secrete growth factors and chemokines. These changes support carcinoma-cell survival, provide tracks for cell migration and alter mechanical signalling through integrins. Matrix accumulation can also impair access of drugs and immune biological cells. Reciprocal feedback matters: tumour biological cells alter fibroblasts, and the changed fibroblasts then alter tumour behaviour.

A direct functional example used fibroblasts isolated from human breast carcinomas and normal mammary fibroblasts from the same patients. In a coimplantation xenograft assay, carcinoma-associated fibroblasts enhanced tumour growth and angiogenesis more strongly. Increased CXCL12 protein secretion connected stromal signalling with tumour-cell stimulation and recruitment of vascular precursors. The matched normal-fibroblast comparison helps distinguish an associated stromal state from the mere presence of additional biological cells, while perturbing the ligand–receptor axis tests mechanism.^[ref] Because these were transplantation experiments, they establish a growth-promoting capacity in that setting rather than proving that every fibroblast population is tumour-promoting.

Tumours also recruit and educate macrophages. Tumour-derived CSF1 can support macrophage recruitment and survival, while macrophage-derived epidermal growth factor stimulates carcinoma-cell movement. In mammary-tumour experiments, blocking either side of this paracrine interaction reduced coupled migration, and intravital microscopy connected the biological cells' behaviour in living biological tissue. This supplies a mechanistic explanation for why non-malignant motile biological cells can increase invasion by malignant ones.^[ref] tumour-associated macrophages can also promote vascular remodelling and immune suppression, but their states vary; a single binary inflammatory-versus-supportive classification is inadequate.

The vascular compartment is another target. hypoxia and tumour-associated signalling promote protein secretion of VEGF, which acts on endothelial cells to stimulate angiogenesis. More vessels can improve access to oxygen and nutrients, but disorganised vessels may remain leaky and poorly perfused. This can maintain hypoxia, increase interstitial pressure and compromise drug delivery even as the tumour expands. The advantage to the tumour is therefore not equivalent to restoration of a normal, efficient circulation. Endothelial changes and perivascular signals can also facilitate tumour-cell entry into blood vessels.

Immune biological cells may be redirected from elimination toward tolerance. Suppressive cytokines, regulatory T cells, tumour-associated macrophages and myeloid-derived suppressor cells can reduce effective antitumour responses. Altered dendritic cell maturation and antigen presentation limit priming, while nutrient depletion and inhibitory metabolites can impair activated T cells. Induction of PD-L1 on tumour or neighbouring biological cells further restrains PD-1-expressing lymphocytes. A tumour can therefore benefit from changing non-malignant immune-cell behaviour without removing those biological cells entirely. Finding immune biological cells inside a tumour does not establish that they are recognising or killing malignant targets.

The same logic can operate at a distance. Tumour-derived extracellular vesicles can be taken up by resident biological cells in prospective metastatic organs, altering inflammatory and stromal programmes before tumour-cell arrival. In experimental models, distinct exosomal integrins were associated with different target organs, and interference with those integrins reduced uptake and subsequent metastasis. Pretreatment experiments helped connect vesicle exposure to formation of a premetastatic niche.^[ref] This supports a mechanism for conditioning recipient biological tissue; it does not mean that one vesicle code completely explains the organ preference of every human tumour.

Reprogramming also includes metabolic cooperation. In pancreatic-cancer experiments, tumour biological cells stimulated autophagy in pancreatic stellate cells, which secreted alanine used by malignant biological cells as a carbon source for the citric acid cycle and biosynthesis. Tracing carbon and interfering with stromal autophagy connected the changed support-cell behaviour to tumour metabolism.^[ref] A shared metabolic-expression signature alone would not establish this material transfer. More generally, to establish a specific transfer, trace labelled substrates into recipient metabolites and biomass, distinguish exchange from independent use of the same nutrient, and block the proposed transport step with rescue by the downstream product. The tumour's advantage should be measured as survival, expansion or invasion under defined conditions.

A general causal design would compare tumour-conditioned and control-conditioned media on purified recipient biological cells, with matched biological cell numbers and viability, then wash and retest recipients to distinguish a persistent state from residual secreted factors. Ligand deletion in tumour biological cells, receptor deletion in recipients and recipient-specific rescue identify directionality. Add-back experiments, direct-contact versus barrier cultures and spatial lineage labels distinguish soluble signals, matrix effects and replacement by contaminating malignant biological cells. In vivo, use cell-type-specific interventions and immune-competent models where immune suppression is the proposed mechanism; a lymphocyte-deficient xenograft cannot establish the full immune interaction.

Importantly, supporting biological cells can also restrain disease. Depletion of alpha-smooth-muscle-actin-positive myofibroblasts in a pancreatic-cancer mouse model reduced fibrosis yet accelerated aggressive disease and immune suppression. The result shows that removing a conspicuous stromal component can eliminate protective functions as well as supportive ones.^[ref] The tumour's advantage emerges from particular reciprocal interactions, so the relevant question is which cell state and function are altered, rather than whether all surrounding normal biological cells are uniformly harmful.

A lymphatic gland is a lymph node; a Lieberkühnian gland is an intestinal crypt; a Brunner gland is a predominantly mucous duodenal gland. The first is a lymphoid organ with traversing lymphatic channels; the other two are epithelial glands opening towards the intestinal lumen. Similar historical terminology must not erase that difference.

A lymph node has a fibrous connective tissue capsule sending trabeculae into the organ and an internal reticular framework supporting mobile cells. Its outer cortex contains lymphoid follicles, whose appearance changes with immune activity; activated secondary follicles have paler germinal centres surrounded by more densely packed lymphocytes. The deeper cortex or paracortex lies between follicular cortex and medulla. The medulla contains branching cellular cords separated by medullary sinuses. A hilum provides the entry and exit of the main blood vessels and the exit of efferent lymphatics.

Afferent lymphatic vessels enter at the convex surface and deliver lymph to the subcapsular sinus. Flow then passes through cortical or trabecular channels into medullary sinuses and out through efferent vessels near the hilum. Macrophages and the reticular arrangement bring carried material into contact with the cellular apparatus. The node's blood circulation is distinct from that lymphatic route. In modern terms, follicles are predominantly B cell territories, the paracortex is rich in T cells, and medullary cords contain many antibody-producing plasma cells. Those cellular classifications go beyond an ordinary 1865 microscopic description.^[ref]

Thin stained sections show the overall architecture, while a silver stain highlights the supporting reticular fibres rather than every lymphocyte. The fibres include type III collagen; the thicker capsule has a different connective-tissue organization. One must not interpret the meshwork itself as an epithelial secretory tube, or assume a section missing the hilum proves that the node has no efferent vessel.^[ref]

The intestinal crypts are simple tubular epithelial invaginations opening between the intestinal villi in the small intestine. Their bases approach the muscularis mucosae, remaining within the mucosa and surrounded by lamina propria. Each gland has a lumen continuous with the intestinal surface and a lining supported by a basement membrane. It contains columnar epithelial cells at different stages of differentiation, goblet cells producing mucus, endocrine cells and, in small-intestinal crypt bases, conspicuous granular Paneth cells. A proliferative compartment supplies replacement cells that move towards the surface; this modern cell-renewal account explains why dividing cells are common in the crypts. Crypts also occur in the colon, whose mucosa lacks ordinary small-intestinal villi. One should therefore specify the region rather than make villi part of every crypt's definition.

A Brunner gland lies chiefly in the submucosa of the proximal duodenum, below the muscularis mucosae. It is a branched, compound tubular gland with pale mucus-rich secretory cells, basal nuclei and small lumina. Its ducts pass through the muscularis mucosae and commonly join overlying intestinal crypts before opening into the lumen. Its alkaline, mucus-rich secretion helps protect the mucosa from acidic gastric contents. The position below the muscularis mucosae distinguishes it particularly well from a Lieberkühn gland in the mucosa.^[ref]

The most useful comparison is consequently one of compartments: a reticular lymphoid organ containing sinuses, a mucosal epithelial tube, and a branched submucosal secretory system. Recognition of the capsule, epithelial lining, muscularis mucosae and duct connections establishes those distinctions more securely than a name alone.

The classical sequence in lobar pneumonia is congestion, red hepatization, grey hepatization, and resolution. These are overlapping morphological phases, not a clock that every pneumonia follows. An affected lung may contain adjacent areas in different phases; bronchopneumonia has scattered airway-centred foci rather than uniform involvement of a whole lobe. Modern antibiotic treatment often interrupts the textbook sequence.^[ref]

During congestion, the lung is heavy, dark red and boggy but still contains some air. Its cut surface gives a blood-stained watery fluid. Microscopy shows distended alveolar capillaries, oedema within alveoli, and an early cellular exudate, before dense pulmonary consolidation has developed. Reduced alveolar ventilation begins as fluid replaces the normal air space.

In red hepatization, the affected lobe is enlarged, firm, red and substantially airless. Its granular cut surface resembles liver, which explains the name; it is not a transformation into liver tissue. The alveoli are occupied by a mesh of fibrin containing abundant red blood cells and neutrophils, while the alveolar capillaries remain congested. Filling of neighbouring air spaces produces continuous pulmonary consolidation. Associated pleurisy may put a fibrinous exudate on the overlying pleura.

In grey hepatization, pulmonary consolidation remains, but the colour becomes grey, grey-brown or yellowish as intact red blood cells disappear and the fibrin and inflammatory leukocytes dominate. Microscopy shows degenerating neutrophils, debris and persistent intra-alveolar fibrin; the conspicuous vascular engorgement of the preceding phase diminishes. Grey colour by itself does not establish a separate pathogen or mean that an abscess has formed.^[ref]

In resolution, the intra-alveolar exudate is broken down, ingested by macrophages, removed through airways and cleared by absorption. The lobe softens and becomes aerated again. Where the alveolar septa have survived, the architecture can return nearly to normal; an air-space exudate need not become a permanent scar. Failure of clearance may instead lead to organisation and fibrosis; destructive infection can produce abscess or empyema. These are possible outcomes, not obligatory further stages.

A useful examination compares a cut section and a thin histological section from each region, following the alveolar septa to distinguish filling of existing air spaces from destruction of the framework. A dense airless piece may sink in water, but this physical test only shows reduced air content: atelectasis can also sink. The distribution and the microscopy establish why the tissue is airless.

“Softening” describes disintegration of nervous tissue; it does not identify one cause. The 1865 colour categories were chiefly red, yellow and white softening. They must be distinguished from the causal classification into vascular injury, inflammation, pressure-related injury, trauma and post-mortem change. Historical observers sometimes interpreted pale ventricular softening as a consequence of oedema; modern pathology requires evidence of tissue death before calling such a region encephalomalacia.^[ref]

Red softening contains conspicuous extravasated blood, sometimes with vascular engorgement. It may occur in a haemorrhagic cerebral infarction, a contusion or destructive inflammation. Yellow softening is a later discoloured, friable focus containing products of tissue and blood breakdown, often with lipid-laden macrophages. White or pale softening has little visible haemorrhage; an ischaemic focus in the white matter can be pale, as can waterlogged tissue around a cerebral ventricle. These appearances overlap through time. Neither red colour proves primary encephalitis nor white colour proves absence of vascular disease.

In the cerebral hemispheres, a major cause of genuine destructive softening is interruption of arterial blood flow: thrombosis on diseased arteries, an embolus from the heart or another artery, or inadequate perfusion during severe systemic circulatory failure. The territory supplied by the obstructed vessel helps explain a focal lesion; prolonged global failure particularly injures vulnerable neurons and boundary zones between arterial territories. Cortical lesions and deep lesions involving the basal ganglia or internal pathways can therefore have different distributions. Cerebral infarction evolves through neuronal injury, removal of dead tissue by microglia and macrophages, and liquefactive necrosis; a chronic lesion may leave a fluid-filled cavity with surrounding gliosis.^[ref]

In the cerebellum and brainstem, interruption of the vertebrobasilar circulation is likewise an important vascular cause; local haemorrhage, trauma and infection are alternatives. Suppuration can cause destructive softening in any region, and a nearby tumour can injure tissue by compression, interference with its blood supply or associated oedema. These mechanisms must be investigated rather than inferred from consistency alone.

In the spinal cord, destructive myelomalacia can follow vascular interruption, severe compression, direct trauma or inflammatory myelitis. Vertebral disease or an epidural mass may compress both the spinal cord and its vessels. Infarction often involves the territory of the anterior spinal artery; reduced perfusion can preferentially damage the vulnerable central gray matter. Myelitis can also disrupt tissue without a primary arterial obstruction. It would be misleading to transfer the relative frequency of cerebral embolism unchanged to every spinal lesion.^[ref]

At examination, record the location, vascular territory, firmness, colour and adjacent membranes; inspect the arteries and search for an embolic source or compression. Microscopy asks whether there is necrosis, inflammatory exudation, haemorrhage, myelin debris, cellular clearance or repair. Finally exclude simple post-mortem autolysis.

The classical contrast is between ulceration centred on intestinal lymphoid tissue in enteric fever and granulomatous, often circumferential ulceration in intestinal tuberculosis. The historical expression continued fever covered more than one illness. The characteristic bowel lesions meant here point especially to typhoid fever; they should not be attributed indiscriminately to typhus or every prolonged fever.

In typhoid fever, Peyer's patches and solitary lymphoid follicles, particularly in the terminal ileum, enlarge and become infiltrated. Their breakdown and necrosis lead to sloughing and ulceration. The larger ulcers characteristically follow the long axis of the intestine, reflecting the shape of the affected aggregated lymphoid patch on the side opposite the mesentery. Depending on their stage, one may see swollen patches, necrotic sloughs, open ulcers or healing surfaces. Depth varies; erosion into a blood vessel can cause haemorrhage, while full-thickness destruction can cause intestinal perforation and peritonitis.

Microscopically, the important cellular component includes swollen macrophages with ingested organisms and cellular debris; this is not simply a dense collection of neutrophils forming an ordinary abscess. The surrounding mucosal architecture may become severely disturbed. These current cellular descriptions refine the gross lesion recognized before the causative organism was identified.^[ref][ref]

In historical phthisis, bowel disease frequently meant intestinal tuberculosis associated with pulmonary tuberculosis. Lesions commonly involve the terminal ileum and ileocaecal region, although other sites occur. Nodules in mucosal or submucosal lymphoid tissue undergo caseous necrosis, coalesce and break through the mucosa. The ulcerated surface tends to spread transversely and may encircle the bowel. The edges can be irregular and undermined, with additional tuberculous granulomas in the wall, serosal surface or draining lymph nodes. Progressive fibrosis may narrow the lumen and produce a stricture; thickened masses as well as ulcers can occur.^[ref]

A section from a tuberculous ulcer may show central caseous necrosis bordered by epithelioid macrophages, giant cells and lymphocytes. A section from an enteric-fever ulcer instead emphasizes destruction of lymphoid patches with macrophage-rich infiltration. A practical anatomical examination records site, orientation, depth, edges, intervening mucosa, serosal nodules and draining lymph nodes, rather than judging one detached fragment in isolation.

Longitudinal lymphoid-patch ulcers favour the classical enteric-fever pattern; transverse, caseating and often stenosing lesions favour intestinal tuberculosis. These are useful patterns rather than absolute rules. Modern microbiological culture, organism-specific molecular tests and appropriately sampled histology can establish the cause when gross appearances overlap.

A phagocyte is a biological cell that takes up particles, such as bacteria or cell debris, by phagocytosis: the cell membrane encloses the material in an intracellular phagosome. Macrophages and neutrophils are important examples. The term describes an uptake capability, rather than a single developmental lineage. Contact with a particle, internalization and destruction of the ingested material are distinct events.

A useful experimental distinction is between phagocytosis and production of reactive oxygen compounds. S. D. Wright and S. C. Silverstein measured hydrogen peroxide released by human granulocytes, monocytes and macrophages spreading on surfaces coated with defined recognition molecules. Surfaces carrying IgG stimulated peroxide release, whereas surfaces carrying C3b or iC3b did not appreciably do so. Even when fibronectin supported a strong complement-receptor-associated phagocytic response in cultured monocytes, measurable peroxide release did not follow.^[ref]

For example, counting ten particle-containing phagosomes would establish uptake in the observed phagocyte; it would not count ten killed bacteria. A killing assay needs a further endpoint, such as recovery of viable organisms. Likewise, a low extracellular peroxide measurement alone does not establish absence of phagocytosis. Choosing an endpoint that matches the biological question is essential when comparing phagocytes.

A phagolysosome is a degradative, particle-containing compartment formed as a phagosome matures through interactions with endosomes and lysosomes. After phagocytosis, the engulfed particle can remain recognizable while its surrounding membrane and contents change. The particle's identity therefore does not establish the biochemical state of the whole compartment.^[ref]

A useful experiment followed low-density latex beads taken up by J774 macrophages. The bead-containing compartments were isolated by flotation on a sucrose gradient. In a pulse-chase analysis, a limited uptake period followed by different waiting intervals yielded compartments of different ages. Comparing their proteins and immunogold labeling revealed changing membrane composition during maturation.^[ref]

Normalization matters when interpreting such images. With invented counts, 10 gold labels along $5\mu \mathrm{m}$ of membrane give $2$ labels per micrometre; 20 labels along $20\mu \mathrm{m}$ give only $1$ label per micrometre. The second sample has more total labels but a smaller label density. Comparing membrane lengths prevents the amount of membrane observed from being mistaken for the abundance of its marker.

That measurement concerns localization of a membrane marker. It is not itself a measurement of luminal pH, degradation rate or killing of a microorganism. Those functions need corresponding observations: acquisition of one marker and completion of a degradative process answer different experimental questions.